FDA Shelf Life Requirements for EO Surgical gown 510k

R

regfocus

#1
We have a 510k under FDA's review. The reviewer kick back the following questions about Shelf life.

FDA Questions:

Shelf Life

You claim that the subject device in sterile packaging has a shelf life of three years, based on testing under accelerated conditions. You did not provide shelf-life testing on real-time aged samples. You did not clearly state if the real time aging is ongoing to confirm the proposed shelf life of the subject device. Also, you did not submit a protocol with the conditions of real time aging and your planned testing at different time points, with acceptance criteria.


To answer FDA's questions,
1) Do we really need to submit a real time aging testing for 3 years?
2) Can we just provide FDA a protocol (claim 3 year shelf life) with a protocol with the conditions of real time aging and our planned testing at different time points, with acceptance criteria, in stead of doing and submitting 3 years real-time aging test now?
3) If we can just submit 3 years real-time aging protocol to FDA, can we get 510k approval letter with 3 years on?
4) Assume we get the 3 years shelf life FDA approval letter, then do we need to submit a 3 years shelf life tests data and report (after 3 years in our testing chamber) to FDA as supplemental files?

You also state that, the subject device is made of polypropylene; therefore, its physical and mechanical properties may not change over shelf life of three years. This is not acceptable. Please provide data to show that physical and mechanical properties of the subject device are maintained in its primary package over the claimed shelf life. Alternatively, please provide scientific justification why you believe additional testing is not needed.

This FDA question is related to the previous FDA's questions. To answer FDA's questions,
1) FDA requested the data to show that physical and mechanical properties of the subject device are maintained in its primary package over the claimed 3 years shelf life. Does that mean we have to wait 3 years to wait this data before we get FDA's 510k approval? In other words, FDA will reject our 510k application because the data we can provide is 3 years in the future.
2) How can we find the scientific justification to support the physical and mechanical properties of subject device made of polypropylene may not change over shelf life of three years?

:rar:
 
Elsmar Forum Sponsor
M

MIREGMGR

#2
Re: FDA Shelf life questions for EO Surgical gown 510k

1) Do we really need to submit a real time aging testing for 3 years?
2) Can we just provide FDA a protocol (claim 3 year shelf life) with a protocol with the conditions of real time aging and our planned testing at different time points, with acceptance criteria, in stead of doing and submitting 3 years real-time aging test now?
Yes, but usually FDA will accept a statement that such testing is under way as long as the testing is documented.

3) If we can just submit 3 years real-time aging protocol to FDA, can we get 510k approval letter with 3 years on?
Yes, usually.

4) Assume we get the 3 years shelf life FDA approval letter, then do we need to submit a 3 years shelf life tests data and report (after 3 years in our testing chamber) to FDA as supplemental files?
No. The RTA data goes into your design files.

1) FDA requested the data to show that physical and mechanical properties of the subject device are maintained in its primary package over the claimed 3 years shelf life. Does that mean we have to wait 3 years to wait this data before we get FDA's 510k approval? In other words, FDA will reject our 510k application because the data we can provide is 3 years in the future.
2) How can we find the scientific justification to support the physical and mechanical properties of subject device made of polypropylene may not change over shelf life of three years?
You made a formal statement to them that the mechanical and physical properties would not change. What evidence was that statement based on? You never want to make a statement to FDA without evidence, because they may call you on it.

If you don't have scientific evidence from someone else's study, for instance by the maker of the material, you'll have to do your own study. You say you already have 3 year AA completed. Did you do before-and-after testing of the relevant parameters for units from that accelerated aging? If so, you'll want to be sure that the same testing is included in your real time aging protocol.
 
R

regfocus

#3
Re: FDA Shelf life questions for EO Surgical gown 510k

Questions:

1) What are the specific properties mean in"physical and mechanical properties of the subject device (surgical gown)"?

2) Do I need to test the properties twice before and after the accelerated shelf life test?

3) Because the shelf life test always degrade the physical and mechanical properties of the subject device, can I just test the properties one time after the accelerated shelf life test instead of before-and-after twice tests? My thought is if the physical and mechanical properties of degraded subject device can meet criteria, why we test before-and-after twice?

Yes, but usually FDA will accept a statement that such testing is under way as long as the testing is documented.

Yes, usually.
No. The RTA data goes into your design files.

You made a formal statement to them that the mechanical and physical properties would not change. What evidence was that statement based on? You never want to make a statement to FDA without evidence, because they may call you on it.

If you don't have scientific evidence from someone else's study, for instance by the maker of the material, you'll have to do your own study. You say you already have 3 year AA completed. Did you do before-and-after testing of the relevant parameters for units from that accelerated aging? If so, you'll want to be sure that the same testing is included in your real time aging protocol.
 
M

MIREGMGR

#4
Re: FDA Shelf life questions for EO Surgical gown 510k

1) What are the specific properties mean in"physical and mechanical properties of the subject device (surgical gown)"?
You have the specific FDA guidance for surgical gowns, right? Section II.D. lists standards for which you must show conformance. Most of those standards will require you to establish material properties or device performance. And, Section II.E. lists specific mechanical and physical parameters that you must compare to your predicate.

Note that the standards list pre-dates AAMI/ANSI PB70. You very likely will be expected to declare a PB70 conformance level, and provide data to support that declaration.

2) Do I need to test the properties twice before and after the accelerated shelf life test?
3) Because the shelf life test always degrade the physical and mechanical properties of the subject device, can I just test the properties one time after the accelerated shelf life test instead of before-and-after twice tests? My thought is if the physical and mechanical properties of degraded subject device can meet criteria, why we test before-and-after twice?
With all due respect, you quoted the FDA examiner above as saying that you told FDA in your initial filing that properties would not change over three years, and now you're saying that aging always causes properties to change? Were you fibbing then, or are you wrong now? If FDA decides you've told an untruth to them, you have a Big Problem.

Yes, you have to test before and after aging. The point is to support your statement that properties won't change over three years.

It'd be nice if I didn't have to mention this, but: note that if FDA thinks you've submitted intentionally fudged data, Really Bad Things could happen.
 
R

regfocus

#5
Re: FDA Shelf life questions for EO Surgical gown 510k

You have the specific FDA guidance for surgical gowns, right? Section II.D. lists standards for which you must show conformance. Most of those standards will require you to establish material properties or device performance. And, Section II.E. lists specific mechanical and physical parameters that you must compare to your predicate.

Note that the standards list pre-dates AAMI/ANSI PB70. You very likely will be expected to declare a PB70 conformance level, and provide data to support that declaration.

With all due respect, you quoted the FDA examiner above as saying that you told FDA in your initial filing that properties would not change over three years, and now you're saying that aging always causes properties to change? Were you fibbing then, or are you wrong now? If FDA decides you've told an untruth to them, you have a Big Problem.

Yes, you have to test before and after aging. The point is to support your statement that properties won't change over three years.

It'd be nice if I didn't have to mention this, but: note that if FDA thinks you've submitted intentionally fudged data, Really Bad Things could happen.
My questions: Our mechanical and physical parameters were tested after accelerated aging and sent to FDA in our initial submission. And we used data after accelerated aging to compare our predicate. In our initial submission, we just mentioned we think these mechanical and physical parameters are not changed during 3 years shelf life due to the material is polypropylene which is stable materials (Maybe this was a bad superfluous)

Put this specific case away, general speaking, the properties test are required for both before and after aged samples (no matter accelerated/real-time aging) for any sterilized medical device?
 
B

blargon

#7
Great feedback from MIREGMGR.
Have you real-time aging data for your predicate device?
 
R

regfocus

#8
Re: FDA Shelf life questions for EO Surgical gown 510k

Yes, that's correct.
FDA requested to provide real-time aging protocol to determine the 3 years shelf life claim for surgical gown.

1) I found there is a FDA guidance - Recommended Protocol for Real-Time Aging of Medical Gloves
to Determine Shelf Life on page 7

http://www.fda.gov/OHRMS/DOCKETS/98fr/994487gd.pdf

But it is for Medical Gloves, how can I draft a protocol for surgical gown? Just change the name of medical gloves to surgical gown? That's it?

2) Is there any FDA Guidance or FDA recognized standards addressed how to plan a protocol?



3)
 
M

MIREGMGR

#9
Re: FDA Shelf life questions for EO Surgical gown 510k

http://www.fda.gov/OHRMS/DOCKETS/98fr/994487gd.pdf

But it is for Medical Gloves, how can I draft a protocol for surgical gown? Just change the name of medical gloves to surgical gown?
No. The Guidance is just that...a guidance. You aren't trying to write a guidance. Your protocol will want to be written to follow the guidance, in general, taking into account that your product is different. You'll be writing rules for what you'll do test-wise, so your language will be mostly Shalls instead of Shoulds.
 
R

regfocus

#10
Re: FDA Shelf life questions for EO Surgical gown 510k

No. The Guidance is just that...a guidance. You aren't trying to write a guidance. Your protocol will want to be written to follow the guidance, in general, taking into account that your product is different. You'll be writing rules for what you'll do test-wise, so your language will be mostly Shalls instead of Shoulds.
FDA guidance - Recommended Protocol for Real-Time Aging of Medical Gloves to Determine Shelf Life on page 7

http://www.fda.gov/OHRMS/DOCKETS/98fr/994487gd.pdf

It says --
5.3 ?Baseline? gloves should meet the ?Before Accelerated Aging? requirements for tensile strength and percent elongation as set forth in the appropriate standard. All gloves aged 6 months and greater should meet the ?After Accelerated Aging? requirements for tensile strength and percent elongation as set forth in the appropriate standard.

My question:
1) What does the "Baseline" here mean?
2) This is a real time aging study, why should meet the ?Before Accelerated Aging? requirements and ?After Accelerated Aging? requirements?

:magic::magic:
 
Thread starter Similar threads Forum Replies Date
I Device Shelf Life Extension to 48 months without involving the FDA 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 1
S COTS (commercial off-the-shelf) Validation FDA Requirements Software Quality Assurance 4
J Is Device Tracking Card an actual requirement under FDA regulation? Other US Medical Device Regulations 0
T Definition Human Use (FDA) Definitions, Acronyms, Abbreviations and Interpretations Listed Alphabetically 7
K FDA 510k electrosurgery 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 0
J Leveraging FDA 510k Clearance for International Registrations Other Medical Device Regulations World-Wide 2
shimonv FDA News FDA guidance on Multiple Function Device Products (8/2020) Other US Medical Device Regulations 1
N FDA UDI - Label vs. Labeling - Does the insert need to include UDI? Other US Medical Device Regulations 0
J FDA notification of address change US Food and Drug Administration (FDA) 2
N Usability testing required for FDA IDE (investigational device exemption)? Human Factors and Ergonomics in Engineering 3
A FDA Class Classification for a cabinet 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 1
L FDA Biocompatibility Requirements - Transitory Contact Other US Medical Device Regulations 1
Edward Reesor FDA DM and /or Class I Life Saving US Food and Drug Administration (FDA) 0
Watchcat FDA will not tolerate fraud…meaning what, exactly? Other US Medical Device Regulations 6
K FDA Premarket Cybersecurity Guidance - 4 questions Other US Medical Device Regulations 5
gunnyshore Form FDA 3500A MedWatch eSubmitter 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 5
Watchcat FDA Webinar Series - N95 Respirators Other US Medical Device Regulations 0
M Off-Label Use - Clarification of FDA Policy US Food and Drug Administration (FDA) 1
J Sub-supplier change from manual to automated process - same specs - Report to FDA? 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 2
C FDA Establishment registration - Buying some medical devices from another manufacturer Medical Device and FDA Regulations and Standards News 5
I How to classify a medical device based on FDA? 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 3
dinaroxentool Question about FDA Classification of a Device 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 3
S The US FDA requirements on Disposal of a medical device US Food and Drug Administration (FDA) 1
S FDA Requirements for Medical Device Label Reconciliation 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 1
S What is considered a "core algorithm"? (From an FDA guidance document) Medical Information Technology, Medical Software and Health Informatics 4
B FDA-Medical Device Reporting (MDR )procedure compliant with 21CFR section 803 US Food and Drug Administration (FDA) 0
Stoic Are any medical device companies using the 2011 FDA process validation guidance instead of GHTF/SG3/N99-10:2004? 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 1
D ISO 13485, FDA 21 CFR 820 and Auditing the Accounting Department ISO 13485:2016 - Medical Device Quality Management Systems 5
S FDA's E submitter - For clinical electronic thermometer Medical Device and FDA Regulations and Standards News 6
J FDA wants electrical safety testing on battery powered medical device US Food and Drug Administration (FDA) 11
A FDA and NB audit of Engineering Drawings in DHF and DMR. Medical Device and FDA Regulations and Standards News 1
D FDA De Novo Cover Letter - What is expected US Food and Drug Administration (FDA) 3
Ed Panek 21 CFR Part 820 - FDA Label Requirements 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 8
J Mislabeling - Consider this an FDA notified recall? CFR 806.10 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 2
O Hospital-Developed, In-House Device - FDA Clearance? Other US Medical Device Regulations 19
D FDA Approved Class II Medical Device? Other US Medical Device Regulations 11
R When does the FDA consider a component a medical device? 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 17
N Risk Management besides mandated FDA requirements 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 1
M Informational US FDA – Ear, Nose, and Throat Devices; Classification of the Self-Fitting Air-Conduction Hearing Aid Medical Device and FDA Regulations and Standards News 0
L UDI Requirments Gap Analysis - EU MDR vs FDA CFR EU Medical Device Regulations 8
M Informational US FDA – Modifications to the List of Recognized Standards, Recognition List Number: 052 Medical Device and FDA Regulations and Standards News 0
M Informational US FDA Draft Guidance – Breast Implants – Certain Labeling Recommendations to Improve Patient Communication Medical Device and FDA Regulations and Standards News 0
M Looking for third party reviewers for FDA submissions US Food and Drug Administration (FDA) 2
M Informational Work in progress at the FDA for biological evaluation – Color Hazard and RISk calculator (CHRIS) Medical Device and FDA Regulations and Standards News 0
M Informational US FDA – CDRH Proposed Guidances for Fiscal Year 2020 (FY 2020) Medical Device and FDA Regulations and Standards News 0
M Informational US FDA Final Guidance – Coronary, Peripheral, and Neurovascular Guidewires – Performance Tests and Recommended Labeling Medical Device and FDA Regulations and Standards News 0
M Informational US FDA Final Guidance – Intravascular Catheters, Wires, and Delivery Systems with Lubricious Coatings – Labeling Considerations Medical Device and FDA Regulations and Standards News 0
T Clinical trial - Medical device product not cleared (without FDA approval) in a drug trial Other US Medical Device Regulations 9
William55401 How Often Does FDA State Consultant Recommended in a Pharma WL? US Food and Drug Administration (FDA) 1
M Informational US FDA – URGENT/11 Cybersecurity Vulnerabilities in a Widely-Used Third-Party Software Component May Introduce Risks During Use of Certain Medical Dev Medical Device and FDA Regulations and Standards News 0

Similar threads

Top Bottom